Search results

Filters
Close
ADDED DATE
Added date
TOPICS Please select
WATCH / LISTEN / READ TIME
RDW Prognostic Marker in HF and Predictor for Iron Replacement Responsivene
Author(s): Artemio García-Escobar , Rosa Lázaro-García , Javier Goicolea-Ruigómez , et al Added: 1 year ago

Heart Failure
Iron Deficiency in LVAD Patients
Author(s): William Herrik Nielsen , Finn Gustafsson Added: 1 year ago

Heart Failure
ESC 23: The HEART-FID Study
Author(s): Robert Mentz Added: 2 years ago
ESC 2023 — Dr Robert Mentz (Duke University Medical Center, US) joins us to provide a succinct summary of the findings and key take-home messages from the HEART-FID study (NCT03037931). HEART-FID(American Regent, Inc.) aimed to determine the safety and efficacy of iron therapy using intravenous (IV) ferric carboxymaltose (FCM) as compared to a placebo in the treatment of patients with heart… View more

Heart Failure
Quality of Life After AVR
Author(s): Meng He , Jinwei Zhang , Jianbo Yu , et al Added: 8 months ago

Heart Failure
TAVR is Ready for Most Low-risk Patients
Author(s): Ahmad Jabri , Anas Alameh , Gennaro Giustino , et al Added: 1 year ago

Intervention

Vascular Disease and Surgery
ACC 25: The MyPEAK-1 Study
Author(s): Milind Y Desai Added: 9 months ago
ACC 2025 - First-in-human results from MyPEAK-1 show Tn-201 treatment in adults with Mybpc3-associated hypertropic cardiomyopathy was feasible and safe.Dr Milind Desai (Cleveland Clinic, Ohio, US) joins us onsite at ACC 2025 to discuss phase Ib/2a results from the first-in-human, non-randomized study investigating the safety and early efficacy of Tn-201, an adeno-associated virus serotype 9 gene… View more

Heart Failure
TCT 24: The TAVR UNLOAD Trial
Author(s): Nicolas M Van Mieghem Added: 1 year ago
TCT Conference 2024 - Safety and efficacy outcomes of transcatheter aortic valve replacement (TAVR) in addition to optimal heart failure therapy (OHFT) compared to OHFT alone in patients with heart failure and moderate aortic stenosis.Dr Nicolas M Van Mieghem (Erasmus University Medical Center, Rotterdam, NL) joins us onsite at TCT Conference to discuss the findings from TAVR UNLOAD (NCT02661451)… View more

Heart Failure

Intervention
e-SPACE Heart Failure 2023
Author(s): Stefan Anker , Giuseppe Rosano , Javier de Juan Bagudá , et al Added: 2 years ago
Translational Medicine Academy (TMA) in partnership with Radcliffe Cardiology were delighted to announce the return of e-SPACE Heart Failure 2023. A thoughtfully curated programme supported the exploration of how leading experts are implementing the new heart failure guidelines into clinical practice and showed the latest information on patient profiling in heart failure for tailoring… View more

Heart Failure

Prevention & Chronic Conditions
Piotr Ponikowski
Research Area(s) / Expertise: Job title: Head of the Department of Heart Diseases
Piotr Ponikowski is Head of the Department of Heart Diseases, Wroclaw Medical University and Head of the Cardiology Department at the Center for Heart Diseases at 4th Military Hospital, Wroclaw, Poland. His research interests mainly include heart failure (HF), coronary artery disease and cardiac arrhythmias. He has been involved in numerous research projects, such as the benefits of physical… View more
Metabolic Factors Now Key Drivers of Heart Failure
Added: 1 week ago Source:  Radcliffe Cardiology
The primary drivers of heart failure (HF) have shifted significantly over the past 35 years, with metabolic conditions such as obesity and diabetes now playing a more prominent role than traditional risk factors like myocardial infarction (MI).¹˒² This finding comes from a large US-based study analysing national health trends.MethodologyResearchers conducted a retrospective analysis of data from… View more

Cardiovascular Renal Metabolic

Heart Failure